This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Beginners often wonder which card type to choose. This intro compares secured vs unsecured options and provides starter tips.
22,834 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Rumors say PayPal might be acquired. Here’s how I’m evaluating the scenario, the potential outcomes, and the concrete...
The crypto world is buzzing about XRP and a potential 90% plunge. This article breaks down the history, risk factors,...
A big earnings event could flip the script for Microsoft stock. This article breaks down why the bold idea of a parab...
Equities cling to gains near all-time highs as hedge funds maintain elevated short positions. A possible Iran deal fu...
Even with rising mortgage costs and tight supply, single women are buying homes at record levels, redefining ownershi...
A trio of high-yield names—PNNT, GLAD, and KRP—show divergent payout reliability even as yields approach double digit...
This in-depth analysis breaks down Acre's Q1 2026 earnings call, pulling out practical takeaways for investors. Learn...
The latest april jobs report shows a modest 115,000 payroll gain with unemployment steady at 4.3%, but revisions and ...
A mounting deficit of $3.4 trillion is shaping long-term borrowing costs, with the 30-year fixed mortgage lingering n...
A Live Oak Bancshares CEO sold 20,000 shares for roughly $769,000 in mid-June. Is this a warning sign or routine dive...
Broadcom is pursuing a bold AI compute strategy that could reshape its growth trajectory. This article breaks down th...